S

ShareHope Medicine Co Ltd
TPEX:8403

Watchlist Manager
ShareHope Medicine Co Ltd
TPEX:8403
Watchlist
Price: 19.2 TWD -0.52%
Market Cap: NT$2.6B

Wall St Price Targets

Price Targets Summary
ShareHope Medicine Co Ltd

There are no price targets for ShareHope Medicine Co Ltd.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
ShareHope Medicine Co Ltd Competitors:
Price Targets
APO
Apollo Global Management Inc
5% Upside
COHU
Cohu Inc
22% Upside
OGI
OrganiGram Holdings Inc
71% Upside

Revenue
Forecast

7% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
7% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is -6%.

Gross Profit
Forecast

6% / Year
Past Growth
-4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
6% / Year
Past Growth
-4% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 8 years is -4%.

Operating Income
Forecast

5% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
5% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 8 years is 3%.

Pre-Tax Income
Forecast

3% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
3% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 8 years is 3%.

Net Income
Forecast

5% / Year
Past Growth
0% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
5% / Year
Past Growth
0% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 8 years is 0%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ShareHope Medicine Co Ltd's stock price target?
Not Available

ShareHope Medicine Co Ltd does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for ShareHope Medicine Co Ltd?
Projected CAGR
-6%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is -6%.

What is the Gross Profit forecast for ShareHope Medicine Co Ltd?
Projected CAGR
-4%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 8 years is -4%.

What is the Operating Income forecast for ShareHope Medicine Co Ltd?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 8 years is 3%.

What is the Pre-Tax Income forecast for ShareHope Medicine Co Ltd?
Projected CAGR
3%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 8 years is 3%.

What is the Net Income forecast for ShareHope Medicine Co Ltd?
Projected CAGR
0%

Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 8 years is 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett